Mortality Risk of Hypnotics: Strengths and Limits of Evidence Daniel F. Kripke Current Opinion 13 November 2015 Pages: 93 - 107
Appropriate Polypharmacy and Medicine Safety: When Many is not Too Many Cathal A. CadoganCristín RyanCarmel M. Hughes Current Opinion Open access 21 December 2015 Pages: 109 - 116
Testosterone Replacement Therapy and Mortality in Older Men G. I. Hackett Review Article 19 October 2015 Pages: 117 - 130
Tools for Assessing Potential Significance of Pharmacist Interventions: A Systematic Review Thi-Ha VoBruno CharpiatOn Behalf of the Working Group “Standardizing and Demonstrating the Value of Clinical Pharmacy Activities” of the French Society for Clinical Pharmacy Systematic Review 09 December 2015 Pages: 131 - 146
Safety of Dalbavancin in the Treatment of Skin and Skin Structure Infections: A Pooled Analysis of Randomized, Comparative Studies Michael W. DunneGeorge H. TalbotSailaja Puttagunta Original Research Article Open access 29 December 2015 Pages: 147 - 157
Adverse Drug Reactions Reported to a National HIV & Tuberculosis Health Care Worker Hotline in South Africa: Description and Prospective Follow-Up of Reports Christine NjugunaAnnemie StewartKaren Cohen Original Research Article 07 November 2015 Pages: 159 - 169
Consumer Understanding, Preferences, and Responses to Different Versions of Drug Safety Messages in the United States: A Randomized Controlled Trial Lauren McCormackR. Craig LefebvrePaula Rausch Original Research Article Open access 07 November 2015 Pages: 171 - 184
Traceability of Biologics in The Netherlands: An Analysis of Information-Recording Systems in Clinical Practice and Spontaneous ADR Reports Kevin KleinJoep H. G. SchollPieter Stolk Original Research Article Open access 30 December 2015 Pages: 185 - 192